Mylan Nv Ord Shs (MYL) 46.74 $MYL Mylan Launches Generic

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Mylan Nv Ord Shs (MYL) 46.74 $MYL

Mylan Launches Generic Dexedrine® Capsules
PR Newswire - Mon Aug 01, 6:30AM CDT
Mylan N.V. (NASDAQ, TASE: MYL) today announced the U.S. launch of Dextroamphetamine Sulfate Extended-release Capsules, 5 mg, 10 mg, and 15 mg, a generic version of Amedra Pharmaceuticals LLC's Dexedrine®. Mylan received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for this product, which is indicated in narcolepsy and attention deficit disorder with hyperactivity as an integral part of a total treatment program that typically includes other measures (psychological, educational, social) for patients (ages 6 years to 16 years) with this syndrome.(1)
MYL: 46.74 (-0.05)

Mylan Launches Generic Propecia® Tablets
PR Newswire - Mon Aug 01, 6:00AM CDT
Mylan N.V. (NASDAQ, TASE: MYL) today announced the U.S. launch of Finasteride Tablets USP, 1 mg, a generic version of Merck's Propecia®. Mylan received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for this product, which is indicated for the treatment of male pattern hair loss (androgenetic alopecia) in men only.
MRK: 58.66 (unch), MYL: 46.74 (-0.05)

Mylan Falls 1.36% on Heavy Volume: Watch For Potential Rebound
Comtex SmarTrend(R) - Thu Jul 28, 1:42PM CDT
Mylan (NASDAQ:MYL) traded in a range yesterday that spanned from a low of $45.82 to a high of $46.92. Yesterday, the shares fell 1.4%, which took the trading range below the 3-day low of $46.38 on volume of 1.7 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
MYL: 46.74 (-0.05)

Look for Shares of Mylan to Potentially Rebound after Yesterday's 1.36% Sell Off
Comtex SmarTrend(R) - Thu Jul 28, 1:41PM CDT
Mylan (NASDAQ:MYL) traded in a range yesterday that spanned from a low of $45.82 to a high of $46.92. Yesterday, the shares fell 1.4%, which took the trading range below the 3-day low of $46.38 on volume of 1.7 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
MYL: 46.74 (-0.05)

Zacks.com featured highlights: Korea Electric Power, Third Point Reinsurance, Mylan N.V. and Gray Television
Zacks Equity Research - Zacks Investment Research - Thu Jul 28, 8:30AM CDT
Zacks.com featured highlights: Korea Electric Power, Third Point Reinsurance, Mylan N.V. and Gray Television
KEP: 27.37 (+0.18), MYL: 46.74 (-0.05), TPRE: 12.60 (+0.01), GTN: 9.78 (-0.12)

Mylan Receives U.S. FTC Clearance for Proposed Meda Acquisition
PR Newswire Europe - Wed Jul 27, 4:19PM CDT
Mylan Has Now Received All Antitrust Regulatory Clearances to Acquire Meda
MYL: 46.74 (-0.05)

4 Buy-Rated Stocks with High Earnings Yield
Zacks Equity Research - Zacks Investment Research - Wed Jul 27, 8:21AM CDT
Earnings yield is a useful ratio for investors who have exposure to both stocks and bonds.
KEP: 27.37 (+0.18), TPRE: 12.60 (+0.01), MYL: 46.74 (-0.05), GTN: 9.78 (-0.12)

The Zacks Analyst Blog Highlights: Manulife Financial, Mylan, Huntsman, Air Lease and Bofi Holding
Zacks Equity Research - Zacks Investment Research - Mon Jul 18, 8:30AM CDT
The Zacks Analyst Blog Highlights: Manulife Financial, Mylan, Huntsman, Air Lease and Bofi Holding
BOFI: 16.09 (-0.73), MFC: 13.42 (-0.21), AL: 28.58 (-0.23), MYL: 46.74 (-0.05), HUN: 15.41 (-0.05)

6 Stocks Still Trading Cheap in Today's Market
Zacks Equity Research - Zacks Investment Research - Fri Jul 15, 2:58PM CDT
We believe it's time to let go of popular stocks and instead focus on the ones trading below fair value.
BOFI: 16.09 (-0.73), MFC: 13.42 (-0.21), AL: 28.58 (-0.23), MYL: 46.74 (-0.05), HUN: 15.41 (-0.05), IX: 69.93 (-0.24)

Market Updates on Drugs - Generic Equities -- Mylan, Horizon Pharma, Allergan, and Diplomat Pharmacy
PR Newswire - Fri Jul 15, 6:30AM CDT
On Thursday, July 14, 2016, the NASDAQ Composite ended the trading session at 5,034.06, up 0.57%; the Dow Jones Industrial Average edged 0.73% higher, to finish at 18,506.41; and the S&P 500 closed at 2,163.75, up 0.53%. The gains were broad based as eight out of nine sectors ended the session in positive. Stock-Callers.com has initiated coverage on the following equities: Mylan N.V. (NASDAQ: MYL), Horizon Pharma PLC (NASDAQ: HZNP), Allergan PLC (NYSE: AGN), and Diplomat Pharmacy Inc. (NYSE: DPLO). Learn more about these stocks by accessing their free notes at:
AGN: 254.86 (+1.91), DPLO: 35.72 (-0.21), HZNP: 18.89 (-0.40), MYL: 46.74 (-0.05)

Teva (TEVA) Provides 2016-2019 Outlook, Shares Gain
Arpita Dutt - Zacks Investment Research - Thu Jul 14, 7:10AM CDT
Teva (TEVA) provided its preliminary outlook for 2016-2019 and expects the Actavis Generics acquisition to go through anytime soon.
AGN: 254.86 (+1.91), MYL: 46.74 (-0.05), TEVA: 53.61 (+0.11), RDY: 44.50 (+0.85)

Looking For Generic Drug Stocks? Pick Up These Winners
Zacks Premium Research - Zacks Investment Research - Wed Jul 13, 5:27PM CDT
The short term earnings outlook for these stocks have been building momentum recently, so don't miss out!
MYL: 46.74 (-0.05), RDY: 44.50 (+0.85), AMPH: 16.29 (+0.11)

SmarTrend Watching for Potential Pullback in Shares of Mylan After 1.51% Gain
Comtex SmarTrend(R) - Wed Jul 13, 12:01PM CDT
Mylan (NASDAQ:MYL) traded in a range yesterday that spanned from a low of $45.43 to a high of $46.78. Yesterday, the shares gained 1.5%, which took the trading range above the 3-day high of $45.39 on volume of 2.3 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
MYL: 46.74 (-0.05)

Teva Raises Q2 Guidance; to Unveil 2016-2019 View
Zacks Equity Research - Zacks Investment Research - Wed Jul 13, 6:47AM CDT
Ahead of its acquisition of Allergan's Generics business, Teva Pharmaceutical (TEVA) raised its second-quarter 2016 guidance for earnings and revenues.
IPXL: 31.15 (-0.27), AGN: 254.86 (+1.91), MYL: 46.74 (-0.05), TEVA: 53.61 (+0.11)

Mylan Launches Generic Temodar® Capsules
PR Newswire - Mon Jul 11, 6:30AM CDT
Mylan N.V. (NASDAQ, TASE: MYL) today announced the U.S. launch of Temozolomide Capsules, 5 mg, 20 mg, 100 mg, 140 mg, 180 mg and 250 mg, which is a generic version of Merck's Temodar®. Mylan received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for this product. Temozolomide Capsules are indicated for the treatment of adult patients with newly diagnosed cancerous tumors known as glioblastoma multiforme concomitantly with radiotherapy and then as maintenance treatment.
MRK: 58.66 (unch), MYL: 46.74 (-0.05)

Mylan to Report Second Quarter 2016 Financial Results on August 9, 2016
PR Newswire - Thu Jul 07, 9:47AM CDT
Mylan N.V. (NASDAQ, TASE: MYL) today announced that it will host a conference call and live webcast, on Tuesday, August 9, 2016, at 4:30 p.m. EDT, to review the company's financial results for the second quarter ended June 30, 2016. Mylan will release its financial results on August 9, after the close of the U.S. financial markets.
MYL: 46.74 (-0.05)

Mylan Launches Generic Fenoglide® Tablets
PR Newswire - Wed Jul 06, 6:30AM CDT
Mylan N.V. (NASDAQ, TASE: MYL) today announced the U.S. launch of Fenofibrate Tablets USP, 40 mg and 120 mg, which is a generic version of Santarus's Fenoglide®. Mylan received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for this product, which is indicated as adjunctive therapy to diet to reduce elevated low-density lipoprotein cholesterol, total cholesterol, Triglycerides, and apolipoprotein B to increase high-density lipoprotein in adult patients with primary hypercholesterolemia or mixed dyslipidemia.
MYL: 46.74 (-0.05)

Mylan Launches Generic Avodart® Capsules
PR Newswire - Fri Jun 24, 10:44AM CDT
Mylan N.V. (NASDAQ, TASE: MYL) today announced the U.S. launch of Dutasteride Capsules, 0.5 mg, the generic version of GlaxoSmithKline's Avodart® Capsules. Mylan received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for this product, which is indicated as monotherapy for the treatment of symptomatic benign prostatic hyperplasia (BPH) in men with an enlarged prostate to improve symptoms, reduce the risk of acute urinary retention and reduce the risk of the need for BPH-related surgery. It may also be used with tamsulosin for the treatment of symptomatic BPH in men with an enlarged prostate.
MYL: 46.74 (-0.05), GSK: 45.25 (+0.18)

Mylan Donates EUR 1 Million to the Princess Máxima Center for Pediatric Oncology
PR Newswire - Thu Jun 23, 10:22AM CDT
Mylan N.V. (NASDAQ, TASE: MYL), one of the world's leading pharmaceutical companies, today announced a EUR 1 million donation to the Princess Máxima Center for Pediatric Oncology, a new national cancer center currently being built in Utrecht, the Netherlands.
MYL: 46.74 (-0.05)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Insight Into Midland TX Real Estate Sales Timing

Updated Category News Views 70

How Fast Do Homes Move in Midland? This ain't my first rodeo predicting the real estate rollercoaster in Texas. Midland's housing market is one nifty beast—homes can either sell like hotcakes or just sit gathering dust. You got HelloNation pulling in DeLaura Gammage, a pro who knows the terrain like the back of her hand, to spell out the why and how long it'll take to...

Continue Reading
Radnostix Sees Mixed Results, Plans Strategic Shift

Updated Category News Views 90

Radnostix: A Rocky Third Quarter with Glimmers of Hope Alright, sit back and digest this: Radnostix, the company once known as International Isotopes Inc., is currently in the midst of a renovation of sorts. They just reported their financial results for the third quarter of 2026, and honestly, they're a mixed bag. Revenue Falls but Theranostics Shines Quarterly revenue...

Continue Reading
PEGATRON Unveils AI and HPC Advances at SC26

Updated Category News Views 96

Revamping AI with High-Density Computing You know, back in the day, AI was just about training models and running basic inference. But now, it's all about these crazy agentic AI tasks—autonomous agents doing things I couldn't have imagined. PEGATRON's Evolution in Infrastructure PEGATRON's latest move at SC26 is a real leap forward in this ongoing AI saga. They're...

Continue Reading
Mall of America Strives for World Record This Black Friday

Updated Category News Views 228

History in the Making at Mall of America Yeah, it seems these folks are not just about shopping anymore. The Mall of America is aiming to set the bar high this Black Friday, eyeing a GUINNESS WORLD RECORDS title for the most people holding up the same shopping bag all at once. Imagine a thousand people, synchronized like a flash mob—only with shopping bags instead of...

Continue Reading
Lilly Endowment Boosts Military Families with $10M Grant

Updated Category News Views 70

A Game-Changer for Semper Fi & America's Fund Dive in, folks. What we've got here is a hefty chunk of change — $10 million to be precise — dropped into Semper Fi & America's Fund's lap by Lilly Endowment Inc. We're talking about a grant designed to shore up the long-term support system crafted for the brave souls in military families. It’s about time a significant...

Continue Reading
Silvi's Expansion Push: New Terminal in Wilmington

Updated Category News Views 166

Silvi's Latest Bet on the Southeast You know, sometimes you get a gut feeling that a company is rolling out chess moves instead of checkers. That’s what Silvi Materials is up to with their new project in Wilmington. It’s not just some fancy cement terminal—it’s a calculated expansion into the heart of the Southeast construction market. The Port of Wilmington’s...

Continue Reading
PawnMate Boosts Inventory Efficiency for Pawnshops

Updated Category News Views 85

RFID Technology: Breathing New Life into Pawnshops Let's get things rolling with the cold, hard truth that pawnshops aren't exactly what most folks expect when it comes to cutting-edge technology. But times are a-changin', and PawnMate’s RFID Inventory Module is the latest twist in this industry storyline. It's like swapping out a rusty toolbox for a brand-new set of...

Continue Reading
Lululemon Faces Class Action: Navigating Investor Impact

Updated Category News Views 103

Lululemon's Legal Storm: Understanding the Background If you thought the yoga gear game was all about stretch and flexibility, Lululemon Athletica, Inc (NASDAQ: LULU) just yanked us back to reality. The company finds itself in a legal tangle with its shareholders following a dismal performance report and a subsequent lawsuit. This situation has unfolded like a second-rate...

Continue Reading
Saint Luis Rey Launches Exclusive Palatinos Vitola

Updated Category News Views 110

New Beginnings for the Saint Luis Rey Brand You think you've seen it all in the cigar world, but then comes a debut like this that lights a fire under the lush tradition of Cuba. Enter Saint Luis Rey's new Palatinos vitola, a blend wrapped in the mystique of exclusivity for La Casa del Habano and Habanos Specialists. Whether you're a seasoned connoisseur or just dipping...

Continue Reading
Texxon Faces Revenue Slide Amid Strategic Shifts

Updated Category News Views 83

Texxon's Strategic Transitions and Financial Headaches Texxon Holding Limited (NASDAQ:NPT) just laid their cards on the table, unveiling a mixed bag in their fiscal year 2026 results. As the world's chemical and plastics scene faces winds of change, Texxon buckled down and tried to steer the ship clear from the rocks. It's a balancing act juggling market headwinds, a new...

Continue Reading

Top 5 Most Recently Viewed Articles

Insights into abrdn Japan Equity Fund's Tender Offer Strategy

Updated Category News Views 303

Understanding the Tender Offer and Reorganization Process abrdn Japan Equity Fund, Inc. (NYSE: JEQ) is entering an exciting phase as it moves forward with additional details regarding its tender offer and the anticipated reorganization with abrdn Global Infrastructure Income Fund (NYSE: ASGI). As this process unfolds, it is essential for investors to grasp the key details...

Continue Reading
TriNet Welcomes Sidney Majalya as New Chief Legal Officer

Updated Category News Views 158

TriNet Welcomes New Chief Legal Officer TriNet, a prominent provider of comprehensive human resources solutions tailored for small and medium-sized businesses, has recently undergone notable leadership changes. The company is excited to announce the appointment of Sidney Majalya as its new Chief Legal Officer and Secretary, marking an important milestone in its evolution....

Continue Reading
Exploring the Future Growth of the SDx Market by 2034

Updated Category News Views 94

Understanding the Growth of the Software-Defined Anything Market The global Software-Defined Anything (SDx) market is experiencing a remarkable transformation. Recently, it was reported that the market is set to grow from USD 44.46 billion in 2024 to an estimated USD 383.65 billion by 2034, achieving a compound annual growth rate (CAGR) of 24.0%. This expansion signals a...

Continue Reading
Safe Harbor Financial Strengthens Position After Successful Capital Raise

Updated Category News Views 245

Safe Harbor Financial's Significant Achievements Recently, Safe Harbor Financial, known as SHF Holdings, Inc. (NASDAQ: SHFS), celebrated a considerable milestone. They regained compliance with Nasdaq's listing requirements, proving their resiliency in the dynamic financial services sector aimed at the cannabis industry. This success was paired with a noteworthy capital...

Continue Reading
UNITE's Dignity Index: Insights from the Vance-Walz Debate

Updated Category News Views 125

UNITE Unveils Dignity Index Results Post-Debate UNITE, a non-profit organization aimed at reducing political divisions, recently showcased its Dignity Index scores following the Vice-Presidential debate between Senator J.D. Vance and Governor Tim Walz. This initiative was co-founded by Tim Shriver, who emphasizes the importance of dignity in political discourse. The...

Continue Reading